Once PD-L1, expressed on cell surface membranes of various cancers and macrophages in tumor tissue [5,6,7,8], binds to PD-1 on the activated cytotoxic T cells, immune checkpoint signaling pathways are activated, and these shut down antitumor T cell immunity [9]. This evidence concerns the gene PDCD1 and neoplasm.